|
gptkbp:instance_of
|
gptkb:Assistive_technology
|
|
gptkbp:approves
|
contraception
|
|
gptkbp:availability
|
prescription required
|
|
gptkbp:brand
|
gptkb:Liletta
|
|
gptkbp:clinical_trial
|
studied for efficacy
studied for safety
|
|
gptkbp:clinical_use
|
long-term contraception
emergency contraception (off-label)
|
|
gptkbp:contraindication
|
pregnancy
active pelvic infection
uterine abnormalities
|
|
gptkbp:demographics
|
women of reproductive age
|
|
gptkbp:duration
|
up to 3 years
|
|
gptkbp:events
|
recommended after insertion
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Liletta
|
|
gptkbp:ingredients
|
gptkb:levonorgestrel
|
|
gptkbp:insertion_procedure
|
performed by healthcare provider
|
|
gptkbp:is_effective_against
|
over 99% effective
|
|
gptkbp:manufacturer
|
gptkb:Allergan
|
|
gptkbp:marketed_as
|
gptkb:Australia
gptkb:Canada
gptkb:United_States
|
|
gptkbp:mechanism_of_action
|
prevents ovulation
thickens cervical mucus
inhibits sperm movement
|
|
gptkbp:patient_education
|
informed consent required
discuss insertion and removal process
discuss potential side effects
|
|
gptkbp:previous_name
|
levonorgestrel IUD
|
|
gptkbp:price
|
varies by location
|
|
gptkbp:regulatory_compliance
|
gptkb:FDA
gptkb:Health_Canada
gptkb:TGA_Australia
|
|
gptkbp:release_date
|
gptkb:2015
|
|
gptkbp:removal_procedure
|
performed by healthcare provider
|
|
gptkbp:route_of_administration
|
intrauterine
|
|
gptkbp:side_effect
|
expulsion
perforation
cramping
irregular bleeding
|
|
gptkbp:bfsParent
|
gptkb:levonorgestrel
|
|
gptkbp:bfsLayer
|
5
|